| scholarly article | Q13442814 |
| P50 | author | Kedra Wallace | Q56256861 |
| Babbette LaMarca | Q88459247 | ||
| P2093 | author name string | Denise Cornelius | |
| P2860 | cites work | Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats | Q28571017 |
| Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion | Q46877931 | ||
| Insulin resistance in preeclampsia | Q46919162 | ||
| Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood | Q47890265 | ||
| Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. | Q51139503 | ||
| Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. | Q51359651 | ||
| Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. | Q52087250 | ||
| Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. | Q52933863 | ||
| Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. | Q52940276 | ||
| Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. | Q53600812 | ||
| Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. | Q54661322 | ||
| Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of Preeclampsia | Q56981931 | ||
| Dysregulation of the Circulating and Tissue-Based Renin-Angiotensin System in Preeclampsia | Q56981959 | ||
| CD19 + CD5 + Cells as Indicators of Preeclampsia | Q59906564 | ||
| Maternal fetal/placental interactions and abnormal pregnancy outcomes | Q79372322 | ||
| Questionable role of the angiotensin II receptor subtype 1 autoantibody in the pathogenesis of preeclampsia | Q80336129 | ||
| Hypertension during pregnancy: a disorder begging for pathophysiological support | Q81397976 | ||
| Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature | Q81423834 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy | Q33607465 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1 | Q34117998 | ||
| Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy | Q34182166 | ||
| A study of angiotensin II pressor response throughout primigravid pregnancy | Q34512573 | ||
| Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. | Q34702420 | ||
| Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes | Q35029700 | ||
| CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy | Q35130793 | ||
| Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease | Q35143007 | ||
| Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction | Q35576417 | ||
| Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia | Q35681821 | ||
| Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia | Q35715914 | ||
| Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats | Q35994304 | ||
| Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling | Q36050771 | ||
| Preeclampsia serum upregulates CD40/CD40L expression and induces apoptosis in human umbilical cord endothelial cells | Q36112505 | ||
| Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system. | Q36115279 | ||
| IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy | Q36178540 | ||
| Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation | Q36244980 | ||
| Preeclampsia: recent insights | Q36288757 | ||
| Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia | Q36355165 | ||
| Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats | Q36683260 | ||
| Immunoregulation in normal pregnancy and pre-eclampsia: an overview | Q36684096 | ||
| Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature | Q36914728 | ||
| Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin? | Q37131819 | ||
| Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension | Q37353499 | ||
| Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats | Q37436219 | ||
| Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
| Immunology of pre-eclampsia | Q37717752 | ||
| Changes of NK cells in preeclampsia | Q37987977 | ||
| Natural killer cells in human pregnancy | Q38083839 | ||
| Preeclampsia: an endothelial cell disorder | Q41281924 | ||
| Placental cytokines and the pathogenesis of preeclampsia | Q41452017 | ||
| Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction | Q43744794 | ||
| TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas | Q45102738 | ||
| Functional changes of human peripheral B-lymphocytes in pre-eclampsia | Q46064047 | ||
| Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia | Q46332630 | ||
| Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia | Q46433836 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | arterial hypertension | Q41861 |
| maternal health | Q6786626 | ||
| P304 | page(s) | 225-233 | |
| P577 | publication date | 2013-07-01 | |
| P1433 | published in | Physiology | Q1091804 |
| P1476 | title | Elucidating immune mechanisms causing hypertension during pregnancy | |
| P478 | volume | 28 |
| Q36339336 | An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia |
| Q35153877 | CD4+ T cells are important mediators of oxidative stress that cause hypertension in response to placental ischemia. |
| Q61812466 | Decidual natural killer cells: A critical pregnancy mediator altered in preeclampsia |
| Q34360684 | Differential effects of complement activation products c3a and c5a on cardiovascular function in hypertensive pregnant rats |
| Q47711388 | Elevated Vasopressin in Pregnant Mice Induces T Helper Subset Alterations Consistent with Human Preeclampsia. |
| Q36635518 | Fetal programming and cardiovascular pathology |
| Q40779892 | Hypertension in an Animal Model of HELLP Syndrome is Associated With Activation of Endothelin 1. |
| Q91750198 | Hypertensive disorders of pregnancy are associated with an inflammatory state: evidence from hematological findings and cytokine levels |
| Q37139722 | Identifying immune mechanisms mediating the hypertension during preeclampsia |
| Q36409599 | Immune Mechanisms Linking Obesity and Preeclampsia |
| Q64227446 | Immune imbalance is associated with the development of preeclampsia |
| Q89860687 | Inflammasomes-A Molecular Link for Altered Immunoregulation and Inflammation Mediated Vascular Dysfunction in Preeclampsia |
| Q27303128 | Neutrophil Depletion Attenuates Placental Ischemia-Induced Hypertension in the Rat |
| Q39423454 | Pathophysiology and Current Clinical Management of Preeclampsia |
| Q44805494 | Physiology in perspective: addressing cardiovascular health and disease. |
| Q92071244 | Placental CD4+ T cells isolated from preeclamptic women cause preeclampsia-like symptoms in pregnant nude-athymic rats |
| Q37451544 | Placental Ischemia and Resultant Phenotype in Animal Models of Preeclampsia |
| Q36584747 | Preeclampsia and Pregnancy-Related Hypertensive Disorders |
| Q41653771 | Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat. |
| Q49813818 | Selective inhibition of 20-hydroxyeicosatetraenoic acid lowers blood pressure in a rat model of preeclampsia |
| Q39107964 | Sex differences in stroke across the lifespan: The role of T lymphocytes |
| Q37385038 | TH17- and IL-17- mediated autoantibodies and placental oxidative stress play a role in the pathophysiology of pre-eclampsia |
| Q26863600 | The complement system and adverse pregnancy outcomes |
| Q33834419 | The role of inflammation in the pathology of preeclampsia |
| Q26801481 | Vitamin D and Inflammatory Cytokines in Healthy and Preeclamptic Pregnancies |
| Q26769601 | Vitamin D and the Promotion of Long-Term Metabolic Health from a Programming Perspective |
| Q36699839 | Vitamin D supplementation improves pathophysiology in a rat model of preeclampsia |
Search more.